Shares of Ironwood Pharmaceuticals IRWD plunged 31.5% yesterday after it announced regulatory updates on the next-generation GLP-2 analog, apraglutide, which is being developed for treating short bowel...
Investors in Ironwood Pharmaceuticals, Inc. IRWD need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 18, 2024 $2.50 Put had some of the highest...
The Chart of the Day belongs to the gastrointestinal pharmaceutical products company Ironwood Pharmaceutical (IRWD) I found the stock by using Barchart's powerful screening functions to find stocks...